DTA and Healthware Partner to Build European Coalition for Digital Therapeutics
The Digital Therapeutics Alliance (DTA) and Healthware will partner to form a coalition convening stakeholders from across the European region to discuss and develop pathways for the recognition of digital therapeutics at the global level. The first in-person meeting of the coalition will take place at Frontiers Health Global in October in Milan, Italy. The coalition will focus on co-creating a vision for the future by analyzing existing frameworks and infrastructure to build an environment to ensure safe and effective DTx therapies to be accessible to patients anywhere.The partnership between Healthware and DTA will develop resources to advance digital therapeutics to transform global healthcare through education, advocacy, and cross-industry collaboration.
Read more about this news release here.
FDA issues de novo clearance for SonoMotion’s Stone Clear device, for kidney stone treatment
Stone Clear is the first and only device cleared by the FDA that uses external ultrasound pulses to facilitate passage of post-lithotripsy kidney stone fragments without surgery.
